W Ray Kim

9PUBLICATIONS
20CO-AUTHORS
Nanotoxicology, health and safetySemi- and unsupervised learningChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 31, 2023
Diagnostic and prognostic performance of the SAFE score in non-alcoholic fatty liver disease.

Guanlin Li, Huapeng Lin, Pimsiri Sripongpun

|Aug 14, 2023
Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver disease.

Vivek Charu, Jane W Liang, Ajitha Mannalithara

|Apr 28, 2023
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B.

Young-Suk Lim, W Ray Kim, Douglas Dieterich

|Apr 26, 2022
Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply.

W Ray Kim, Laura E Telep, Anand P Chokkalingam

|Feb 09, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.

W Ray Kim, Laura E Telep, Belinda Jump

|Mar 27, 2021
Predicting Survival After Liver Transplantation: A Noble Pursuit or a Fool's Errand?

Allison J Kwong, W Ray Kim

Pageof 2

Frequent Collaborators

3 joint publications

Allison Kwong

2 joint publications

Anand P Chokkalingam

1 joint publications

Deirdre Mladsi

1 joint publications

Kavita Aggarwal